4.3 Article

Glucocorticoid sensitization of microglia in a genetic mouse model of obesity and diabetes

Journal

JOURNAL OF NEUROIMMUNOLOGY
Volume 269, Issue 1-2, Pages 20-27

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jneuroim.2014.01.013

Keywords

Obesity; Inflammation; Hippocampus; Corticosterone; Glucocorticoid

Funding

  1. National Institutes of Health [K01DK100616]
  2. Diabetes and Obesity Discovery Institute of Georgia Regents University

Ask authors/readers for more resources

db/db mice are a model of obesity and diabetes due to their lack of functional leptin receptors, which leads to insulin resistance, elevated corticosterone levels, and persistent inflammation. Because stress-induced elevations in glucocorticoids sensitize microglia to immune challenges, we hypothesized that corticosteroids might act similarly in the diabetic brain. To test this hypothesis, db/db and wildtype mice were treated with the glucocorticoid synthesis inhibitor metyrapone every day for 2 weeks. This treatment revealed corticosterone-dependent increases in microglial number and accumulation of the pro-inflammatory cytokines interleukin Theta and tumor necrosis factor alpha in the hippocampus of db/db mice. Analysis of microglial responses to lipopolysaccharide stimulation revealed that glucocorticoids lower the threshold for release of pro-inflammatory cytokines, underscoring the role of corticosteroids as a precipitating factor for neuroinflammation in obesity and diabetes. (C) 2014 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available